Evidence map›Paper›PMID 20445501›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2010

Calcium/calmodulin-dependent protein kinase II mediates hippocampal glutamatergic plasticity during benzodiazepine withdrawal.

Guofu Shen, Bradley J Van Sickle, Elizabeth I Tietz

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. GABAFrontiers in psychiatry · 2022
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Guofu ShenDepartment of Physiology and Pharmacology, University of Toledo College of Medicine, Health Science Campus, Toledo, OH 43614, USA.
Bradley J Van Sickle
Elizabeth I Tietz
University of Toledo · US

Funding

Benzodiazepine-Induced Glutamate Receptor PlasticityR01DA018342 · NIDA · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI TIETZ, ELIZABETH I · 2005 to 2009
$1.5M
GLUTAMATE RECEPTORS IN FLURAZEPAM-TOLERANT HIPPOCAMPUSF30DA006041 · NIDA · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI VAN SICKLE, BRADLEY JAMES · 2000 to 2003
$120k
NIDA NIH HHS F30 DA006041NIDA NIH HHS F30-DA06041NIDA NIH HHS R01 DA018342NIDA NIH HHS R01-DA18342
6 · The paper itself

Abstract

Benzodiazepine withdrawal anxiety is associated with potentiation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor (AMPAR) currents in hippocampal CA1 pyramidal neurons attributable to increased synaptic incorporation of GluA1-containing AMPARs. The contribution of calcium/calmodulin-dependent protein kinase II (CaMKII) to enhanced glutamatergic synaptic strength during withdrawal from 1-week oral flurazepam (FZP) administration was further examined in hippocampal slices. As earlier reported, AMPAR-mediated miniature excitatory postsynaptic current (mEPSC) amplitude increased in CA1 neurons from 1- and 2-day FZP-withdrawn rats, along with increased single-channel conductance in neurons from 2-day rats, estimated by non-stationary noise analysis. Input-output curve slope was increased without a change in paired-pulse facilitation, suggesting increased AMPAR postsynaptic efficacy rather than altered glutamate release. The increased mEPSC amplitude and AMPAR conductance were related to CaMKII activity, as intracellular inclusion of CaMKIINtide or autocamtide-2-related inhibitory peptide, but not scrambled peptide, prevented both AMPAR amplitude and conductance changes. mEPSC inhibition by 1-naphthyl acetyl spermine and the negative shift in rectification index at both withdrawal time points were consistent with functional incorporation of GluA2-lacking AMPARs. GluA1 but not GluA2 or GluA3 levels were increased in immunoblots of postsynaptic density (PSD)-enriched subcellular fractions of CA1 minislices from 1-day FZP-withdrawn rats, when mEPSC amplitude, but not conductance, was increased. Both GluA1 expression levels and CaMKII alpha-mediated GluA1 Ser(831) phosphorylation were increased in PSD-subfractions from 2-day FZP-withdrawn rats. As phospho-Thr(286)CaMKII alpha was unchanged, CaMKII alpha may be activated through an alternative signaling pathway. Synaptic insertion and subsequent CaMKII alpha-mediated Ser(831) phosphorylation of GluA1 homomers contribute to benzodiazepine withdrawal-induced AMPAR potentiation and may represent an important hippocampal pathway mediating both drug-induced and activity-dependent plasticity.

Indexed as

HippocampusAnimalsBehavior, AnimalBenzodiazepinesBiophysical PhenomenaBiophysicsCalcium-Calmodulin-Dependent Protein Kinase Type 2Disease Models, AnimalDrug InteractionsElectric StimulationEnzyme InhibitorsExcitatory Amino Acid AgentsFlurazepamGene Expression Regulation, EnzymologicGlutamic AcidHypnotics and SedativesBenzodiazepinesCalcium-Calmodulin-Dependent Protein Kinase Type 2Enzyme InhibitorsExcitatory Amino Acid AgentsFlurazepamGlutamic AcidHypnotics and SedativesReceptors, Glutamate

Identifiers

PMID20445501
PMCPMC2904841
OpenAlexW2018201264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.